ATE492269T1 - Verfahren für die zubereitung einer isotonischen wässrigen ropivacain-injektion - Google Patents

Verfahren für die zubereitung einer isotonischen wässrigen ropivacain-injektion

Info

Publication number
ATE492269T1
ATE492269T1 AT06770886T AT06770886T ATE492269T1 AT E492269 T1 ATE492269 T1 AT E492269T1 AT 06770886 T AT06770886 T AT 06770886T AT 06770886 T AT06770886 T AT 06770886T AT E492269 T1 ATE492269 T1 AT E492269T1
Authority
AT
Austria
Prior art keywords
ropivacain
injection
isotonic aqueous
ropivacaine
base
Prior art date
Application number
AT06770886T
Other languages
English (en)
Inventor
Christopher N Jobdevairakkam
Jagadeesh B Rangisetty
Original Assignee
Navinta Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027513&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE492269(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Navinta Llc filed Critical Navinta Llc
Application granted granted Critical
Publication of ATE492269T1 publication Critical patent/ATE492269T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT06770886T 2005-05-25 2006-05-22 Verfahren für die zubereitung einer isotonischen wässrigen ropivacain-injektion ATE492269T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/137,256 US20060270708A1 (en) 2005-05-25 2005-05-25 Novel process for preparation of isotonic aqueous injection of ropivacaine
PCT/US2006/019804 WO2006127639A2 (en) 2005-05-25 2006-05-22 Process for preparation of isotonic aqueous injection of ropivacaine

Publications (1)

Publication Number Publication Date
ATE492269T1 true ATE492269T1 (de) 2011-01-15

Family

ID=37027513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06770886T ATE492269T1 (de) 2005-05-25 2006-05-22 Verfahren für die zubereitung einer isotonischen wässrigen ropivacain-injektion

Country Status (14)

Country Link
US (1) US20060270708A1 (de)
EP (1) EP1883392B1 (de)
JP (1) JP2008545694A (de)
AT (1) ATE492269T1 (de)
AU (1) AU2006251583A1 (de)
CA (1) CA2608730A1 (de)
CY (1) CY1111445T1 (de)
DE (1) DE602006019085D1 (de)
DK (1) DK1883392T3 (de)
ES (1) ES2358884T3 (de)
PL (1) PL1883392T3 (de)
PT (1) PT1883392E (de)
SI (1) SI1883392T1 (de)
WO (1) WO2006127639A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051144A1 (it) * 2005-06-17 2006-12-18 Molteni & C Dei Fratellei Alit "procedimento per la preparazione d'una soluzione iniettabile di (2s)-n-(2;6-dimetil-fenil)-1-propil-2-piperidincarbossiamide"
CN102697708A (zh) * 2012-04-17 2012-10-03 上海禾丰制药有限公司 盐酸罗哌卡因注射液及其制剂工艺
LT3331516T (lt) * 2015-07-13 2024-12-27 Neon Laboratories Ltd. Ropivakaino hidrochlorido hiperbarinis injekcinis tirpalas ir jo paruošimo procesas
CN105816432B (zh) * 2016-03-24 2020-02-07 成都天台山制药有限公司 注射用冷冻干燥盐酸罗哌卡因组合物及其质量控制方法
CN106177970B (zh) * 2016-07-12 2019-09-17 扬子江药业集团有限公司 罗哌卡因注射用制剂及其制备方法和应用
JP2020519593A (ja) * 2017-05-11 2020-07-02 ステディメッド， エルティーディー．Ｓｔｅａｄｙｍｅｄ， Ｌｔｄ． 溶解度を増強させた薬物含有製剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2797241A (en) * 1953-08-28 1957-06-25 Brown Charles Leslie Meredith Diethyl-glycinexylidide and process
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
US6156900A (en) * 1994-10-07 2000-12-05 Darwin Discovery Limited Racemization of precursors to levobupivacaine and analogues thereof
MX9703025A (es) * 1994-10-25 1997-10-31 Chiroscience Ltd Proceso para preparar levobupivacaina y sus analogos.
SE9501808D0 (sv) * 1995-05-16 1995-05-16 Astra Ab New process
BR9707081A (pt) * 1996-01-25 1999-05-25 Schering Ag Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal
IL129951A0 (en) * 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
BR9814883A (pt) * 1997-11-19 2000-10-03 Darwin Discovery Ltd Formulação anestésica
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
JPWO2003024930A1 (ja) * 2001-09-10 2004-12-24 メルシャン株式会社 ピペコリン酸アミド誘導体の製造方法

Also Published As

Publication number Publication date
ES2358884T3 (es) 2011-05-16
PL1883392T3 (pl) 2011-07-29
WO2006127639A2 (en) 2006-11-30
CA2608730A1 (en) 2006-11-30
SI1883392T1 (sl) 2011-07-29
JP2008545694A (ja) 2008-12-18
DK1883392T3 (da) 2011-04-18
AU2006251583A1 (en) 2006-11-30
CY1111445T1 (el) 2015-08-05
US20060270708A1 (en) 2006-11-30
EP1883392A2 (de) 2008-02-06
EP1883392B1 (de) 2010-12-22
WO2006127639A3 (en) 2007-05-18
DE602006019085D1 (de) 2011-02-03
PT1883392E (pt) 2011-03-29

Similar Documents

Publication Publication Date Title
HRP20202017T1 (hr) Sintetski međuprodukt koristan u dobivanju triazolopiridina inhibitora c-met
CY1111445T1 (el) Μεθοδος παρασκευης ισοτονης υδατικης ενεσης ροπιβακαϊνης
BR112013014715B8 (pt) processo para produzir um artigo oco polimérico
MX358345B (es) Una forma amorfa y una cristalina de hemitartrato de genz 112638 como inhibidor de glucosilceramida sintasa.
HRP20110425T1 (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
MX390583B (es) Producto base de quelación para uso en tratamientos de sistemas a base de agua y método para producir el producto base.
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
ATE522497T1 (de) Verfahren zur herstellung eines glutaminsäurederivats, ein pyroglutaminsäurederivat und ein neues zwischenprodukt für die herstellung
DE602005000334D1 (de) Verfahren zur herstellung von oxycodon
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
CY1111914T1 (el) Μεθοδος συνθεσης της ιβαβραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
BRPI0907999A2 (pt) processo de preparação de combretastatina
FI3331516T3 (fi) Ropivakaiinihydrokloridin hyperbaarinen liuosinjektio ja menetelmä sen valmistamiseksi
MX2011007006A (es) Sal doble de acido de cefdinir y su preparacion.
ATE461924T1 (de) Verfahren zur herstellung von rosuvastatin und intermediate
RU2008105019A (ru) N-замещенные 4-метил-2,6-дихлорникотиноил-мочевины в качестве антидотов 2,4-д на подсолнечнике
AR056181A1 (es) Procedimiento para producir nonapeptido leuprolida
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
ATE512947T1 (de) Herstellung von alkylketen-dimeren
ATE423775T1 (de) Verfahren zur herstellung von lactonen
BRPI0909752A2 (pt) método para a produção de sulfonilpirróis como inibidores de hdac
RU2006128805A (ru) Способ получения 3-тиа-1,5-диазабицикло[4,3,1]декана и 5-[4-(1,3,5-дитиазинан-5-ил)бутил]1,3,5-дитиазинана
ATE501115T1 (de) Verfahren zur herstellung von entacapon
ATE487711T1 (de) Verfahren zur herstellung von metallsalzen von losartan
AR053972A1 (es) Procedimiento para produccion de 2 - cloro-4- nitroimidazol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1883392

Country of ref document: EP